• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Coral Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Coral
  • BSE Code : 3676.0
  • ISIN : INE683E01017
574.65 6 (1.09%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    556.00

  • Today’s High

    586.00

  • Open

    586.00

  • Perv Close

    568.45

  • 52W Low

    360.00

  • 52W High

    659.00

Key Indicators

  • P/E(TTM)

    12.69

  • Mar.Cap (₹Cr.)

    205.15

  • Div & Yield %

    0.35

  • Book Value(₹)

    585.74

  • Debt-Equity Ratio

    1.09

  • AGM Date

    14-Aug-2026

  • EPS

    45.27

  • P/E Ratio

    12.69

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    205.15

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.57

  • BV (₹)

    585.70

  • Sales( ₹ in Cr.)

    85.90

  • NP (in Cr.)

    16.16

  • NP Var(%)

    -35.0

  • Div%

    20.0

  • CPS (₹)

    51.30

  • EPS (₹)

    45.30

  • Traded Value (₹ in Lakhs)

    205.15

  • 52 Week High

    659.00

  • 52 Week Low

    360.00

  • Price BSE

    575.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    205.15

  • P/C Ratio

    11.20

  • P/E Ratio

    12.70

  • Price Vs.BV

    45.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 115.01 83.66 78.12 75.61 96.57 70.58
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 115.01 83.66 78.12 75.61 96.57 70.58
Other Income 9.11 6.63 6.93 5.77 3.79 5.89
Stock Adjustments -3.32 3.13 -3.64 -0.71 0.05 2.94
Total Income 120.80 93.42 81.41 80.67 100.41 79.41
EXPENDITURE :            
Raw Materials 49.70 40.38 42.11 39.01 50.11 42.97
Power and Fuel Cost 3.16 3.05 3.10 2.55 2.05 1.82
Employee Cost 14.74 11.20 11.13 11.23 10.18 9.70
Other Manufacturing Expenses 4.22 3.96 4.55 4.01 5.81 4.64
Selling and Administration Expenses 8.17 8.39 9.55 9.61 9.32 6.45
Miscellaneous Expenses 6.24 3.74 0.23 0.28 3.29 2.52
Employee Benefit Expenses 14.74 11.20 11.13 11.23 10.18 9.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 86.22 70.72 70.68 66.69 80.76 68.10
Operating Profit 34.58 22.71 10.75 13.99 19.64 11.31
Interest 0.10 0.00 0.34 0.14 0.04 0.19
Gross Profit 34.48 22.71 10.41 13.85 19.60 11.12
Depreciation 2.01 1.98 2.18 1.99 1.98 2.01
Profit Before Tax 32.47 20.73 8.23 11.86 17.62 9.11
Current Tax 8.33 4.91 1.82 2.75 4.50 2.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 0.03 -0.04 0.06 -0.44 -0.51
Reported Net Profit 24.16 15.79 6.45 9.05 13.55 7.13
Extraordinary Items -0.57 -0.12 0.03 0.73 0.01 0.00
Adjusted Net Profit 24.73 15.91 6.42 8.32 13.54 7.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -4.37
P & L Balance brought forward 147.46 131.67 125.23 116.18 102.63 105.99
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.71 0.00 0.00 0.00 0.00 0.86
P & L Balance carried down 170.90 147.46 131.67 125.23 116.18 107.89
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 67.61 44.19 18.04 25.32 37.94 19.96
Earnings Per Share(Adj)-Unit Curr 67.61 44.19 18.04 25.32 37.94 19.96
Book Value 563.19 496.83 433.29 436.81 382.48 323.77
Book Value(Adj)-Unit Curr 563.19 496.83 433.29 436.81 382.48 323.77

Shareholding Pattern

  • Promoter Group

    71.51%

  • Public Share Holding

    28.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,841,453 1,841,453.00 1,841,453 1,841,453
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,841,453 51.54 1,841,453 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 713,351 19.97 713,351 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 713,351 19.97 713,351 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 44,148 1.24 44,148 25
Clearing Members 701 0.02 701 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 123,408 3.45 119,408 101
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 41,931 1.17 41,931 131
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 106,665 2.99 106,665 2
Individuals holding nominal share capital up to Rs. 1 lakh 605,266 16.94 562,436 3,603
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 94,346 2.64 94,346 1
Sub Total 1,017,796 28.49 970,966 3,871
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,572,600 100.00 3,525,770 3,873

Company Background

Coral Laboratories LtdPharmaceuticals - Indian - Formulations

  • Coral Laboratories Ltd
  • BSE Code : 3676.0
  • ISIN : INE683E01017

  • Incorporation Year

    1981

  • Registered Office

    SF-206 Silver Oak Complex
    BPC Road, Vadodara,
    Gujarat-390020

  • Telephone

    91-022-2500 5245/46

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    DHWANI KARNA DESAI

  • Auditor

    M A Parekh & Associates/S C Mehra & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Coral Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Coral Labs. 574.65 124.11 115.01 12.52 16.98
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77